CG
EVGN icon

Cutler Group’s Evogene EVGN Stock Holding History

Cutler Group’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-260
Closed -$2K – 2623
2023
Q4 		$2K Hold
260
– – ﹤0.01% 3084
2023
Q3 		$1K Hold
260
– – ﹤0.01% 3488
2023
Q2 		$2K Hold
260
– – ﹤0.01% 3012
2023
Q1 		$1K Hold
260
– – ﹤0.01% 3398
2022
Q4 		$1K Hold
260
– – ﹤0.01% 3988
2022
Q3 		$2K Hold
260
– – ﹤0.01% 4180
2022
Q2 		$2K Hold
260
– – ﹤0.01% 4270
2022
Q1 		$3K Sell
260
-135
-34% -$1.82K ﹤0.01% 4443
2021
Q4 		$6K Buy
395
+8
+2% +$182 ﹤0.01% 4056
2021
Q3 		$10K Sell
387
-415
-52% -$12.1K ﹤0.01% 3921
2021
Q2 		$27K Sell
802
-808
-50% -$31.7K ﹤0.01% 3039
2021
Q1 		$81K Buy
+1,610
New +$99.6K ﹤0.01% 1945

Other funds holding EVGN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Cutler Group's EVGN Position: Q1 2024 in Review

Cutler Group sold out of Evogene (EVGN) in Q1 2024, closing a stake of 260 shares — an estimated $2K sold.

Cutler Group first reported a position in EVGN in Q1 2021 and held it in 12 quarters. The position peaked at $81K in Q1 2021. 29 funds tracked by Wall St. Rank hold EVGN as of Q1 2024.

  • Cutler Group reported no remaining Evogene position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 260 Evogene shares in Q1 2024, an estimated $2K.
  • Cutler Group first reported a position in Evogene in Q1 2021 and held it in 12 quarters.
  • Cutler Group's Evogene position peaked at $81K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Evogene as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.